{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:34:46Z","timestamp":1773077686451,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.dld.2008.02.012","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T12:34:04Z","timestamp":1207226044000},"page":"731-736","source":"Crossref","is-referenced-by-count":53,"title":["In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid na\u00efve patients"],"prefix":"10.1016","volume":"40","author":[{"given":"T.","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Okanobu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kogame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Imagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2008.02.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.dld.2008.02.012_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.dld.2008.02.012_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jcgh.2003.50005","article-title":"Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled study","volume":"1","author":"Hanai","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.012_bib4","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1023\/A:1015330816364","article-title":"Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis","volume":"6","author":"Kashiwagi","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.012_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","article-title":"Selective granulocytes and monocyte adsorptive apheresis as a first-line treatment for steroid na\u00efve patients with active ulcerative colitis: a prospective uncontrolled study","volume":"49","author":"Suzuki","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.012_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.20046","article-title":"Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?","volume":"20","author":"Saniabadi","year":"2005","journal-title":"J Clin Apher"},{"key":"10.1016\/j.dld.2008.02.012_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.dld.2004.08.004","article-title":"Evaluation of granulocyte\/monocyte apheresis therapy for active ulcerative colitis","volume":"36","author":"Kanke","year":"2004","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00054725-200405000-00012","article-title":"Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis","volume":"10","author":"Naganuma","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2004.02189.x","article-title":"Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.02.012_bib10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2004.02288.x","article-title":"Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study","volume":"20","author":"Domenech","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.02.012_bib11","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10620-006-9199-9","article-title":"A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis","volume":"51","author":"Suzuki","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.012_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2249.1991.tb02958.x","article-title":"Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease","volume":"86","author":"McCarthy","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2008.02.012_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/gut.35.5.669","article-title":"Increased macrophage subsets in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes","volume":"35","author":"Rugtveit","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.012_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0016-5085(78)90285-8","article-title":"Macrophage turnover in Crohn's disease and ulcerative colitis","volume":"74","author":"Meuret","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.012_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00024382-200005000-00003","article-title":"Neutrophil apoptosis is delayed in patients with inflammatory bowel disease","volume":"13","author":"Brannigan","year":"2000","journal-title":"Shock"},{"key":"10.1016\/j.dld.2008.02.012_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-5699(95)80066-2","article-title":"The production of cytokines by polymorphonuclear neutrophils","volume":"16","author":"Cassatella","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.dld.2008.02.012_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.42.4.470","article-title":"Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation","volume":"42","author":"Nikolaus","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.012_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ibd.3780060105","article-title":"The key role of macrophages in the immunopathogenesis of inflammatory bowel disease","volume":"6","author":"Mahida","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: Epidemiology, Pathogenesis, and therapeutic opportunities","volume":"12","author":"Hanauer","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib20","series-title":"Inflammatory Bowel Disease","first-page":"15","year":"1998"},{"key":"10.1016\/j.dld.2008.02.012_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","article-title":"Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease","volume":"119","author":"Tibble","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.012_bib22","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1111\/j.1572-0241.2000.03194.x","article-title":"Faecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhoea referred for colonoscopy","volume":"95","author":"Limburg","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.012_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000080079","article-title":"Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid dependent moderately severe ulcerative colitis","volume":"70","author":"Hanai","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2008.02.012_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.02.012_bib25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/gut.2004.056309","article-title":"Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease","volume":"54","author":"Gironella","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.012_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.dld.2007.02.003","article-title":"Leukocytapheresis as promising therapy for inflammatory bowel disease","volume":"39","author":"Caprilli","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.dld.2007.01.010","article-title":"Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients","volume":"39","author":"Takemoto","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.dld.2007.03.007","article-title":"Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?","volume":"39","author":"Pan\u00e9s","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.dld.2007.01.001","article-title":"Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study","volume":"39","author":"Bresci","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.dld.2007.04.007","article-title":"Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis","volume":"39","author":"Yamamoto","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.02.012_bib31","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.156.11.4422","article-title":"Opposing effects of glucocorticoids on the rate of appoptosis in neutrophilic and eosinophilic granulocytes","volume":"156","author":"Meagher","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.dld.2008.02.012_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","article-title":"Therapeutic leucocytapheresis for inflammatory bowel disease","volume":"37","author":"Saniabadi","year":"2007","journal-title":"Transf Apher Sci"},{"key":"10.1016\/j.dld.2008.02.012_bib33","doi-asserted-by":"crossref","unstructured":"Hanai H, Iida T, Takeuchi K, Watanabe F, Yamada M, Kikuyama M, et al. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol 2008, in press.","DOI":"10.1111\/j.1572-0241.2007.01714.x"},{"key":"10.1016\/j.dld.2008.02.012_bib34","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s10620-006-9406-8","article-title":"Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8 and the expression of toll like receptor 2 on granulocytes","volume":"52","author":"Aoki","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.012_bib35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0016-5085(94)90159-7","article-title":"Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial","volume":"107","author":"Lerebours","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.012_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/14712598.5.4.451","article-title":"Clinical application of human CD4+CD25+ regulatory T cells for the treatment of inflammatory bowel diseases","volume":"5","author":"Kanai","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.dld.2008.02.012_bib37","first-page":"295","article-title":"The role of peripheral lymphocytes in the prediction of recurrence in Crohn's disease","volume":"160","author":"Heimann","year":"1985","journal-title":"Surg Gynecol Obstet"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T12:10:29Z","timestamp":1684325429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865808000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1590865808000704"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.02.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}